Warberg Asset Management’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.2K Buy
+35,177
New +$33.6K ﹤0.01% 163
2026
Q2
– Sell
-275,000
Closed -$56.4K – 195
2026
Q1
$56.4K Buy
+275,000
New +$119K 0.01% 146

Other funds holding OTLK

Warberg Asset Management's OTLK Position: Q3 2026 in Review

Warberg Asset Management opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 35,177 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #163 among its holdings. This is a return to the name: Warberg Asset Management previously reported a position in OTLK as recently as Q1 2026.

Warberg Asset Management first reported a position in OTLK in Q1 2026 and has held it in 2 quarters since. The position peaked at $56.4K in Q1 2026. 82 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.

  • Warberg Asset Management held 35,177 shares of Outlook Therapeutics worth $20.2K as of Q3 2026.
  • Outlook Therapeutics was a new Warberg Asset Management position in Q3 2026.
  • Outlook Therapeutics made up ﹤0.01% of Warberg Asset Management's portfolio in Q3 2026, its #163 holding.
  • Warberg Asset Management first reported a position in Outlook Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Warberg Asset Management's Outlook Therapeutics position peaked at $56.4K in Q1 2026.
  • 82 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.

Based on Warberg Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.